Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

NCT00005070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: irofulven

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]